Trial intelligence / Profile preview

Octreotide and Antibiotics in Whipple Procedure

NCT04329039Phase 3Suspended

Sponsor
Mayo Clinic
Start
Nov 2020
Primary completion
May 2027
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of octreotide in pancreatic fistula (POPF), sponsored by Mayo Clinic. Started Nov 2020; status: suspended.

02

Drugs

octreotide
03

Conditions

pancreatic fistula (POPF)

Beyond the preview

Go deeper on NCT04329039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04329039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call